Loading clinical trials...
Loading clinical trials...
RhG-CSF (Filgrastim) Treatment of Severe Epithelial/Endothelial or Solid Organ-Specific Tissue Damage In Stem Cell Transplant Recipients
Conditions
Interventions
Filgrastim
Locations
1
United States
U.T.M.D. Anderson Cancer Center
Houston, Texas, United States
Start Date
February 1, 2003
Primary Completion Date
September 1, 2008
Completion Date
September 1, 2008
Last Updated
August 7, 2012
NCT07070674
NCT00001529
NCT06910969
NCT06660355
NCT07166848
NCT06936566
Lead Sponsor
M.D. Anderson Cancer Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions